Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

Published:2022-04-05 Issue:12 Volume:28 Page:2485-2487
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:

Author:

Henry David H.¹^ORCID,Maki Robert G.¹²^ORCID

Affiliation:

1. 1Pennsylvania Hospital, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

2. 2Hospital of the University of Pennsylvania, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Abstract

Summary Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus—associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm. See related article by Reid et al., p. 2646

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Link

https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-0884/3110520/ccr-22-0884.pdf

Reference37 articles.

1. AMC-070: lenalidomide is safe and effective in HIV-associated Kaposi sarcoma;Reid;Clin Cancer Res,2022

2. Idiopathisches multiples Pigmentsarkom der Haut;Kaposi;Arch Dermatol Syphilol,1872

3. Kaposi virus scores cancer coup;Boshoff;Nat Med,2003

4. Moritz Kaposi (1837–1902);Oriel;Int J STD AIDS,1997

5. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?;Beral;Lancet,1990

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP